BioLineRx Ltd. Reports Third Quarter 2013 Financial Results
11/13/2013 9:51:24 AM
JERUSALEM, Nov. 13, 2013 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, today reported its results for the third quarter ending September 30, 2013.
Kinneret Savitsky, Ph.D., Chief Executive Officer of BioLineRx, stated, "As we approach the end of 2013, we see the Company's continued progress towards several significant catalysts over the next several quarters.
Help employers find you! Check out all the jobs and post your resume.
comments powered by